TECNO Launches Shot On CAMON Contest 2025, Empowering Snapshot Mastery with the CAMON 40 Series
HONG KONG, April 30, 2025 /PRNewswire/ — Today, TECNO, an AI-driven innovative technology brand, officially announced the launch of the Shot On CAMON Contest... Read more.
Heat, drought and high energy bills will impact millions across the US this summer
Temperature departures 3 degrees or higher above the historical average are expected across parts of 14 states this summer The demand for home, business and data... Read more.
Canadian Solar Files Annual Report on Form 20-F for Year Ended December 31, 2024
KITCHENER, ON, April 30, 2025 /PRNewswire/ — Canadian Solar Inc. (the “Company”, or “Canadian Solar”) (NASDAQ: CSIQ), today announced... Read more.
AAON Reports Sales & Earnings for the First Quarter of 2025
TULSA, Okla., April 30, 2025 /PRNewswire/ — AAON, INC. (NASDAQ-AAON), a leader in high-performing, energy-efficient HVAC solutions that bring long-term value... Read more.
LG Display Becomes World’s First to Verify Commercialization of Blue Phosphorescent OLED Panels
Final Step to Achieving “Dream OLED” SEOUL, South Korea, April 30, 2025 /PRNewswire/ — LG Display, the world’s leading innovator of display... Read more.
EntropiQ Expands Quantum Entropy Services Through Collaboration with a Leading Digital Infrastructure Provider
Deployment at Equinix’s Solution Validation Center enables EntropiQ to test and validate Quantum Entropy as a Service solutions in a secure, scalable, and... Read more.
Beacon’s CEO Delivers Congressional Testimony on Fostering U.S. Innovation
WASHINGTON, April 30, 2025 /PRNewswire/ — ML Mackey, CEO of Beacon, recently provided testimony to the House Small Business Committee on the importance of... Read more.
Rediscovering Quality Home Life Through Nature-Inspired Design at 137th Canton Fair
GUANGZHOU, China, April 30, 2025 /PRNewswire/ — In the fast-paced rhythm of modern urban life, a home has evolved beyond being merely a place to rest, it has... Read more.
Satsuma Pharmaceuticals Announces U.S. FDA Approval for Atzumi™ (Dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
Atzumi™ (dihydroergotamine(DHE)) nasal powder is the first and only DHE nasal powder for the acute treatment of migraine with or without aura in adults in an easy-to-use,... Read more.
BC.GAME Launches Phase 2 Social Mining Event: 1 Billion $BC Tokens Up for Grabs
BELIZE CITY, Belize, April 30, 2025 /PRNewswire/ — BC.GAME announced the official launch of the second phase of its $BC mining event, set to begin on May... Read more.